1. Home
  2. KRRO vs ECX Comparison

KRRO vs ECX Comparison

Compare KRRO & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • ECX
  • Stock Information
  • Founded
  • KRRO 2014
  • ECX 2017
  • Country
  • KRRO United States
  • ECX China
  • Employees
  • KRRO N/A
  • ECX N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • ECX EDP Services
  • Sector
  • KRRO Health Care
  • ECX Technology
  • Exchange
  • KRRO Nasdaq
  • ECX Nasdaq
  • Market Cap
  • KRRO 490.1M
  • ECX 584.9M
  • IPO Year
  • KRRO 2019
  • ECX N/A
  • Fundamental
  • Price
  • KRRO $37.61
  • ECX $1.84
  • Analyst Decision
  • KRRO Strong Buy
  • ECX
  • Analyst Count
  • KRRO 7
  • ECX 0
  • Target Price
  • KRRO $133.83
  • ECX N/A
  • AVG Volume (30 Days)
  • KRRO 91.5K
  • ECX 1.6M
  • Earning Date
  • KRRO 11-12-2024
  • ECX 02-26-2025
  • Dividend Yield
  • KRRO N/A
  • ECX N/A
  • EPS Growth
  • KRRO N/A
  • ECX N/A
  • EPS
  • KRRO N/A
  • ECX N/A
  • Revenue
  • KRRO N/A
  • ECX $778,608,168.00
  • Revenue This Year
  • KRRO N/A
  • ECX $20.12
  • Revenue Next Year
  • KRRO N/A
  • ECX $32.70
  • P/E Ratio
  • KRRO N/A
  • ECX N/A
  • Revenue Growth
  • KRRO N/A
  • ECX 25.45
  • 52 Week Low
  • KRRO $30.01
  • ECX $0.96
  • 52 Week High
  • KRRO $98.00
  • ECX $3.09
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 41.52
  • ECX 43.42
  • Support Level
  • KRRO $36.02
  • ECX $1.78
  • Resistance Level
  • KRRO $39.04
  • ECX $1.97
  • Average True Range (ATR)
  • KRRO 3.11
  • ECX 0.13
  • MACD
  • KRRO 0.18
  • ECX -0.02
  • Stochastic Oscillator
  • KRRO 40.57
  • ECX 12.39

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: